Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 11

The impact of ABCB1 (rs1045642 and rs4148738) and CES1 (rs2244613) gene polymorphisms on dabigatran equilibrium peak concentration in patients after total knee arthroplasty [Corrigendum]

Authors Sychev DA, Levanov AN, Shelekhova TV, Bochkov PO, Denisenko NP, Ryzhikova KA, Mirzaev KB, Grishina EA, Gavrilov MA, Ramenskaya GV, Kozlov AV, Bogoslovsky T

Received 23 August 2018

Accepted for publication 23 August 2018

Published 26 September 2018 Volume 2018:11 Pages 167—168

DOI https://doi.org/10.2147/PGPM.S185056


Sychev DA, Levanov AN, Shelekhova TV, Bochkov PO, Denisenko NP, Ryzhikova KA, Mirzaev KB, Grishina EA, Gavrilov MA, Ramenskaya GV, Kozlov AV, Bogoslovsky T. Pharmgenomics Pers Med. 2018;11:127-137.
 
In this paper, the CC genotypes of CES1 (rs2244613) were misrepresented as AA genotypes. For the correct interpretation of the results of this research study, the “AA genotypes” should be corrected to “CC genotypes”. CES1 (rs2244613) genotypes were interpreted incorrectly due to misleading instruction in the RT-PCR commercial kit. Accordingly, in this paper “AA homozygous” should be replaced by “CC homozygous”.

Read the original article.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]